No Data
Reviva Pharm Holdings Price Target Announced at $15.00/Share by EF Hutton
Reviva Pharm Holdings Initiated at Buy by EF Hutton
Express News | Reviva Pharmaceuticals Holdings, Inc. - Statistically Significant Vocal Biomarker Data Reinforce Efficacy of Brilaroxazine
Express News | Reviva Pharmaceuticals Holdings, Inc.: Additional Vocal Biomarker Data From Ongoing Open Label Extension Study Expected Q4 2024
Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating
Maxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)
Lnova : anything in particular that makes you think so?
Clintzilla OP Lnova : just saw this, ill come back to it.. Pipeline i have something wrote down somewhere.. float is bigger than usual but i played this like 3-9 last time